AGP Picks
View all

The Middle East Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.

Press releases published on August 19, 2026

Chaya Lerner Explores the Healing Power of Ancient Jewish Wisdom in “The Torah of Trauma”
From a Scholarship in Haryana to an Eight-Vertical AI Empire: The Vishal Arya Story
H1 2026: Novonesis delivered strong 8% organic sales growth and increases full-year outlook
Drug Screening Market to Grow from USD 10.36 Billion in 2025 to USD 21.29 Billion by 2030, at a CAGR of 15.5%– MarketsandMarkets™
BC health research pursues precision, genetics-based care for three conditions
AI Is Reshaping Veterinary Medicine: Investment Surges as Diagnostic, Documentation, and Remote Monitoring Technologies Gain Traction
DAZED INC. POWERING FORWARD: ANNOUNCES DALLAS EXPANSION BRINGING STORE COUNT TO 13, STRONGER Q2 2026 FINANCIALS, Q4 STOCK BUYBACK PLAN, AND DISTRIBUTION ACCELERATION
Gateway Foundation Rebrands to Alpharus Health
SafeSpace Global and BMRT Security Enter Binding Exclusive Agreement to Advance Detection of Concealed Weapons and Drugs for America’s Schools and Correctional Facilities
QTREX's Patent-Pending Technology Achieves First Direct Conversion of 3D-Printed Insulation into Graphene-Like Carbon to Protect Quantum Processors
Imprivata Recognized in Constellation ShortList™ for Healthcare IT Security
ACTG Evaluates Osteoporosis Treatment as Novel Approach Targeting the HIV Reservoir
Roji Health Intelligence Releases New Guide as CMS Expands the Role of Accountable Care Organizations
Pulmera Expands CBeam™ 3D Imaging Platform into Foot and Ankle Surgery
Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration
Femasys Announces FDA Approval of Modular PMA Submission Approach for FemBloc®
Regional Health Properties Reports Second Quarter 2026 Results
InterCure Ltd. Announces 1-for-5 Reverse Share Split
Cosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%; $5M Share Repurchase Program Underway
Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Middle East Health Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.